Navigation Links
Echo Therapeutics Announces Positive Results from Symphony(TM) Transdermal Continuous Glucose Monitoring System Study at Tufts Medical Center
Date:3/13/2008

able if at least ninety-five percent (95%) of the data points fall within the A/B region, along with negligible or no D/E points. MARD is an error calculation tool that measures the average relative difference between Symphony and the reference measurements, on a percentage basis. A low MARD error, below 20%, is consistent with an accurate device.

Results

Using approximately 1200 hours of continuous data from Symphony and 482 reference BG measurements from the 25 subjects, Clarke Error Grid analysis of the study data showed that Echo's Symphony had over 97% of the data in the combined A and B areas with approximately 70% in the "A" region, 27% in the "B" region, and less than 3% in the "D" region. The MARD for the study was approximately 16%. A total of forty-nine (49) Symphony sensors were used during the study. There were no Symphony failures and no adverse events, indicating strong reliability of the Symphony for applications in the hospital critical care setting.

Conference Call and Webcast Information

The Company will host a conference call at 10:30 AM ET to discuss the data and an update of its pipeline. To access the conference call, please dial 866- 467-0407 (domestic) or 706-902-0164 (international) and reference the conference ID 39282879. A replay of the call will be available from 10:30 a.m. ET on March 13, until March 15, 2008, at midnight. To access the replay, please dial 800-642-1687 (domestic) or 706-645-9291 (international) and reference the conference ID 39282879. A live audio webcast of the call and the archived webcast will be available in the Investors section of the Echo Therapeutics website http://www.echotx.com.

About Echo Therapeutics

Echo Therapeutics is focused on specialty pharmaceuticals and medical devices. Echo is developing novel topical reformulations of FDA-approved products and non-invasive, wireless, transdermal continuous glucose monitori
'/>"/>

SOURCE Echo Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
2. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
3. Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
4. Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes
5. Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Childrens Hospital at Stanford
6. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
7. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
8. Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
9. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
10. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
11. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 24, 2014 Mental health issues ... They break up families, ruin careers, and generally ... for those that suffer,” says Hardy Nutritionals® ... showing that our specialized nutritional treatments can reverse ... on “Mind Over Matter”, the premiere episode of ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 Dr. Michael ... Fertility Center, recently appeared on NBC to discuss egg freezing ... freezing has been trending in the news recently, with new ... procedure for women. , “[The companies] see it ... are on a career hot path.” Says Dr. Kettel. , ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 The ... Market 2006 to 2020 - Asia-Pacific” provides quantitative ... devices market segments: minimally invasive body contouring devices, ... The analysis includes market size data by revenue ... the following countries: China, Japan, South Korea, Australia ...
(Date:11/23/2014)... (HealthDay News) -- The holidays can be a challenge ... can trigger major meltdowns, an expert says. "Holidays ... circumstances, but when you have children with special needs, ... therapy professor at University of the Sciences in Philadelphia, ... to let your hosts or visitors know what special ...
(Date:11/23/2014)... York, NY (PRWEB) November 23, 2014 ... the past month in a federal litigation involving Byetta ... similar diabetes medications, Bernstein Liebhard LLP reports. , ... 566 claims over a class of Type 2 diabetes ... filed in the U.S. District Court, Southern District of ...
Breaking Medicine News(10 mins):Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
... PHILADELPHIA, Dec. 24 Congressman Chaka Fattah (D-PA) releases the ... reform legislation: , "Senate Democrats deserve our thanks and ... to do, but I am confident that the House and ... the new year we will be sending President Obama a ...
... Today, The U.S. Conference of Mayors (USCM) congratulates the U.S. Senate ... millions of the uninsured. In a historic Christmas Eve session, ... Protection and Affordable Care Act. , "Not since 1963, has ... It is appropriate the most important piece of health ...
... cells generate embryonic-like cells, study finds , THURSDAY, Dec. 24 ... fight the common cold and heal wounds, but the antioxidant ... generate embryonic-like stem cells, new research suggests. , The ... Stem Cell , add to previous research that showed how ...
... , WASHINGTON, Dec. 24 "The Senate,s historic vote ... creation of a transformational national long-term services and supports insurance ... people with disabilities. The Senate bill also includes means by ... acute and long-term problems. It will stimulate innovation in ...
... , , WASHINGTON, Dec. ... critical that this step be accomplished as we continue our journey ... committed to working with Congress to ensure health insurance reform is ... Delgado, President and CEO of the National Alliance for Hispanic Health, ...
... of the Bipartisan Policy Center Report Continue to Encourage Joint ... U.S. Senate Majority Leaders Howard Baker, Tom Daschle and Bob ... and Leaders, Project on the State of American Health Care, ... and Affordable Care Act of 2009 today. , ...
Cached Medicine News:Health News:Senate Action Part of Long Road to Health Care Reform 2Health News:Former Senate Majority Leaders Baker, Daschle and Dole Commend Senate Passage of Health Care Bill 2Health News:Former Senate Majority Leaders Baker, Daschle and Dole Commend Senate Passage of Health Care Bill 3
(Date:11/22/2014)... Research and Markets  has announced the addition ... 2014-2017" report to their offering. ... protein drug market has been expanding rapidly owing to ... like. During 2005-2013, sales of recombinant protein drugs available ... 19.1%, and it is projected that ...
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
(Date:11/21/2014)... , Nov. 21, 2014  World Hemp Oil, an ... THC, announces they are now offering legal, organic oil ... Web type strains grown in medical marijuana states. People ... disorders, such as Parkinson,s, MS, and spinal cord injury, ... to pass, because imported CBD Oil Is legal in ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... N.J., Dec. 9, 2011  Saint-Gobain Performance Plastics has upgraded ... new state-of-the art laser engraving system. The system ... or tag of all hose assemblies, piping and ... Saint-Gobain Performance Plastics can engrave crimp collars on ...
... 2011 Gen-Probe Incorporated (NASDAQ: GPRO ) announced today ... Conference in New York on December 14, 2011 at approximately 10:15 ... and may be accessed through a link on the investors section ... available for 30 days following the event. ...
Cached Medicine Technology:Saint-Gobain Introduces Laser Engraving for Hose Assemblies 2Gen-Probe to Webcast Presentation at the Oppenheimer 22nd Annual Healthcare Conference 2
Inquire...
Inquire...
Inquire...
... a range of 18 Ophthalmic frames ... and producted to the very hightest ... super lightweight Titanium and Beta Titanium ... host of beautifully formed and innovative ...
Medicine Products: